Standard Chemical & Pharmaceutical Co. Ltd. (TPE: 1720)

Standard Chemical & Pharmaceutical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,617	2,037	2,259	2,564	1,036	1,472
Short-Term Investments	92.73	60.5	44.36	57.84	308.54	84.45
Trading Asset Securities	155.73	178.29	176.15	134.91	136.56	135.82
Cash & Short-Term Investments	1,866	2,276	2,480	2,757	1,481	1,692
Cash Growth	-26.91%	-8.24%	-10.06%	86.13%	-12.46%	16.66%
Accounts Receivable	1,495	1,263	1,263	1,158	942.84	891.91
Other Receivables	175.34	155.84	216.67	331.82	24.41	24.47
Receivables	1,670	1,419	1,480	1,490	967.25	916.37
Inventory	1,670	1,615	1,386	1,218	893.51	914.63
Prepaid Expenses	133.92	103.09	95.21	86.62	93.16	86.56
Other Current Assets	4.35	5.56	148.27	232.89	166.39	4.29
Total Current Assets	5,344	5,418	5,589	5,784	3,602	3,614
Property, Plant & Equipment	4,343	4,301	3,952	2,955	2,389	2,320
Long-Term Investments	1,559	967.73	844.45	769.34	669.49	619.66
Goodwill	173.91	173.91	173.91	162.24	70.27	70.27
Other Intangible Assets	35.58	40.63	51.08	61.38	18.7	26.32
Long-Term Deferred Tax Assets	140.37	141.31	128.37	141.45	138.59	141.58
Other Long-Term Assets	174.03	146.82	228.68	221.04	161.53	135.84
Total Assets	11,770	11,189	10,968	10,095	7,049	6,928
Accounts Payable	607.28	642.99	686.37	624.35	438.57	421.58
Accrued Expenses	232.93	340.88	290.57	141.95	-	-
Short-Term Debt	319.45	800	1,350	1,358	566	865
Current Portion of Long-Term Debt	59.03	59.03	-	-	-	-
Current Portion of Leases	24.33	24.17	21.21	20.35	17.54	13.35
Current Income Taxes Payable	192.01	235.19	222.04	164.07	99.09	47.93
Current Unearned Revenue	110.56	83.21	84	79.12	135.66	94.03
Other Current Liabilities	925.13	185.41	225.65	328.28	393.76	371.18
Total Current Liabilities	2,471	2,371	2,880	2,716	1,651	1,813
Long-Term Debt	193.46	222.97	182	50	-	-
Long-Term Leases	215.42	221.72	236.7	239.64	201.66	144.11
Long-Term Deferred Tax Liabilities	83.94	84.27	84.67	83.85	61.99	61.99
Other Long-Term Liabilities	12.46	12.3	0.41	0.53	1.37	18.4
Total Liabilities	3,095	3,051	3,533	3,295	2,144	2,282
Common Stock	1,787	1,787	1,787	1,787	1,787	1,787
Additional Paid-In Capital	298.91	223.89	220.48	204.31	203.27	204.51
Retained Earnings	3,267	3,275	2,862	2,461	1,946	1,702
Comprensive Income & Other	466.61	13.18	-115.94	-110.33	29.31	70.52
Total Common Equity	5,820	5,299	4,753	4,342	3,966	3,764
Minority Interest	2,854	2,838	2,682	2,458	939.9	882.21
Shareholders' Equity	8,674	8,137	7,436	6,800	4,906	4,646
Total Liabilities & Equity	11,770	11,189	10,968	10,095	7,049	6,928
Total Debt	811.68	1,328	1,790	1,668	785.2	1,022
Net Cash (Debt)	1,054	947.65	689.98	1,089	696.09	669.71
Net Cash Growth	-3.98%	37.34%	-36.65%	56.47%	3.94%	33.08%
Net Cash Per Share	5.89	5.30	3.86	6.09	3.89	3.74
Filing Date Shares Outstanding	178.7	178.7	178.7	178.7	178.7	178.7
Total Common Shares Outstanding	178.7	178.7	178.7	178.7	178.7	178.7
Working Capital	2,873	3,047	2,710	3,068	1,951	1,801
Book Value Per Share	32.57	29.65	26.60	24.30	22.19	21.06
Tangible Book Value	5,610	5,084	4,528	4,118	3,877	3,668
Tangible Book Value Per Share	31.40	28.45	25.34	23.05	21.70	20.52
Land	770.54	770.54	770.54	496.34	420.37	515.14
Buildings	2,411	2,190	2,055	1,819	1,671	1,571
Machinery	3,858	3,738	3,196	2,738	2,168	2,074
Construction In Progress	194.98	345.85	385.15	171.35	86.34	33.2

Source: S&P Capital IQ. Standard template. Financial Sources.